$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Anti-Influenza Activity of an Ethyl Acetate Fraction of a Rhus verniciflua Ethanol Extract by Neuraminidase Inhibition 원문보기

Oxidative medicine and cellular longevity, v.2020, 2020년, pp.8824934 -   

Kim, Young Soo (Korea Institute of Oriental Medicine (KIOM), Korean Medicine (KM) Application Center, 70 Cheomdan-ro, Dong-gu, Daegu 41062, Republic of Korea) ,  Li, Wei (Korea Institute of Oriental Medicine (KIOM), Korean Medicine (KM) Application Center, 70 Cheomdan-ro, Dong-gu, Daegu 41062, Republic of Korea) ,  Kim, Ji Hye (Korea Institute of Oriental Medicine (KIOM), Korean Medicine (KM) Application Center, 70 Cheomdan-ro, Dong-gu, Daegu 41062, Republic of Korea) ,  Chung, Hwan-Suck (Korea Institute of Oriental Medicine (KIOM), Korean Medicine (KM) Application Center, 70 Cheomdan-ro, Dong-gu, Daegu 41062, Republic of Korea) ,  Choi, Jang-Gi (Korea Institute of Oriental Medicine (KIOM), Korean Medicine (KM) Application Center, 70 Cheomdan-ro, Dong-gu, Daegu 41062, Republic of Korea)

Abstract AI-Helper 아이콘AI-Helper

Antigenic mismatch can cause influenza vaccines to be ineffective, and influenza viruses resistant to antiviral drugs are rising. Thus, development of antiviral agents against these viruses is an immediate need. Rhus verniciflua (RVS) has long been used in herbal medicine and as a nutritional supple...

참고문헌 (45)

  1. 1 Stohr K. Influenza--WHO cares The Lancet Infectious Diseases 2002 2 9 p. 517 10.1016/S1473-3099(02)00366-3 2-s2.0-0036724280 

  2. 2 Azekawa S. Namkoong H. Mitamura K. Kawaoka Y. Saito F. Co-infection with SARS-CoV-2 and influenza A virus IDCases 2020 20, article e00775 10.1016/j.idcr.2020.e00775 

  3. 3 Wehl G. Laible M. Rauchenzauner M. Co-infection of SARS CoV-2 and influenza A in a pediatric patient in Germany Klinische Padiatrie 2020 232 4 217 218 10.1055/a-1163-7385 32392591 

  4. 4 Kondo Y. Miyazaki S. Yamashita R. Ikeda T. Coinfection with SARS-CoV-2 and influenza A virus BML Case Reports 2020 13 7 p. e236812 10.1136/bcr-2020-236812 32611659 

  5. 5 Yue H. Zhang M. Xing L. The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak Journal of Medical Virology 2020 92 11 2870 2873 10.1002/jmv.26163 

  6. 6 Wang C. Takeuchi K. Pinto L. H. Lamb R. A. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block Journal of Virology 1993 67 9 5585 5594 10.1128/JVI.67.9.5585-5594.1993 7688826 

  7. 7 Gubareva L. V. Kaiser L. Hayden F. G. Influenza virus neuraminidase inhibitors Lancet 2000 355 9206 827 835 10.1016/S0140-6736(99)11433-8 2-s2.0-0034603350 10711940 

  8. 8 Stiver G. The treatment of influenza with antiviral drugs CMAJ : Canadian Medical Association Journal = journal de l'Association medicale canadienne 2003 168 1 49 56 12515786 

  9. 9 Jin Z. Smith L. K. Rajwanshi V. K. Kim B. Deval J. The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-triphosphate towards influenza A virus polymerase PLoS One 2013 8 7, article e68347 10.1371/journal.pone.0068347 2-s2.0-84880006467 23874596 

  10. 10 Dias A. Bouvier D. Crepin T. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit Nature 2009 458 7240 914 918 10.1038/nature07745 2-s2.0-67249130012 19194459 

  11. 11 He G. Qiao J. Dong C. He C. Zhao L. Tian Y. Amantadine-resistance among H5N1 avian influenza viruses isolated in northern China Antiviral Research 2008 77 1 72 76 10.1016/j.antiviral.2007.08.007 2-s2.0-37449007681 17897729 

  12. 12 Salter A. Ni Laoi B. Crowley B. Emergence and phylogenetic analysis of amantadine-resistant influenza a subtype H3N2 viruses in Dublin, Ireland, over six seasons from 2003/2004 to 2008/2009 Intervirology 2011 54 6 305 315 10.1159/000321358 2-s2.0-80053992617 21228542 

  13. 13 Hussain M. Galvin H. D. Haw T. Y. Nutsford A. N. Husain M. Drug resistance in influenza A virus: the epidemiology and management Infection and Drug Resistance 2017 Volume 10 121 134 10.2147/IDR.S105473 2-s2.0-85020401536 28458567 

  14. 14 Air G. M. Influenza neuraminidase Influenza and Other Respiratory Viruses 2012 6 4 245 256 10.1111/j.1750-2659.2011.00304.x 2-s2.0-84862003840 22085243 

  15. 15 Air G. M. Ghate A. A. Stray S. J. Influenza neuraminidase as target for antivirals Advances in Virus Research 1999 54 375 402 10.1016/S0065-3527(08)60372-3 10547680 

  16. 16 Colman P. M. Hoyne P. A. Lawrence M. C. Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase Journal of Virology 1993 67 6 2972 2980 10.1128/JVI.67.6.2972-2980.1993 8497041 

  17. 17 Monto A. S. McKimm-Breschkin J. L. Macken C. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use Antimicrobial Agents and Chemotherapy 2006 50 7 2395 2402 10.1128/AAC.01339-05 2-s2.0-33745635392 16801417 

  18. 18 Myers J. L. Hensley S. E. Oseltamivir-resistant influenza viruses get by with a little help from permissive mutations Expert Review of Anti-Infective Therapy 2014 9 4 385 388 10.1586/eri.11.2 2-s2.0-79955088606 21504394 

  19. 19 Fabricant D. S. Farnsworth N. R. The value of plants used in traditional medicine for drug discovery Environmental Health Perspectives 2001 109 Suppl 1 69 75 10.1289/ehp.01109s169 11250806 

  20. 20 Newman D. J. Cragg G. M. Snader K. M. Natural products as sources of new drugs over the period 1981-2002 Journal of Natural Products 2003 66 7 1022 1037 10.1021/np030096l 2-s2.0-0042844744 12880330 

  21. 21 Li W. Kim T. I. Kim J. H. Chung H. S. Immune checkpoint PD-1/PD-L1 CTLA-4/CD80 are blocked by Rhus verniciflua Stokes and its active compounds Molecules 2019 24 22 

  22. 22 Kadokura K. Suruga K. Tomita T. Novel urushiols with human immunodeficiency virus type 1 reverse transcriptase inhibitory activity from the leaves of Rhus verniciflua Journal of Natural Medicines 2015 69 1 148 153 10.1007/s11418-014-0871-7 2-s2.0-84915823562 25349048 

  23. 23 Kang S. Y. Kang J. Y. Oh M. J. Antiviral activities of flavonoids isolated from the bark of Rhus verniciflua stokes against fish pathogenic viruses in vitro Journal of Microbiology 2012 50 2 293 300 10.1007/s12275-012-2068-7 2-s2.0-84860355352 

  24. 24 Choi J. G. Jin Y. H. Lee H. Protective effect of Panax notoginseng root water extract against influenza A virus infection by enhancing antiviral interferon-mediated immune responses and natural killer cell activity Frontiers in Immunology 2017 8 p. 1542 10.3389/fimmu.2017.01542 2-s2.0-85034075252 

  25. 25 Perez J. T. Garcia-Sastre A. Manicassamy B. Insertion of a GFP reporter gene in influenza virus Current Protocols in Microbiology 2013 29 1 15G.4.1 15G.4.16 10.1002/9780471729259.mc15g04s29 2-s2.0-84880679703 

  26. 26 Manicassamy B. Manicassamy S. Belicha-Villanueva A. Pisanelli G. Pulendran B. Garcia-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus Proceedings of the National Academy of Sciences of the United States of America 2010 107 25 11531 11536 10.1073/pnas.0914994107 2-s2.0-77954889069 20534532 

  27. 27 Choi J. G. Lee H. Hwang Y. H. Lee J. S. Cho W. K. Ma J. Y. Eupatorium fortunei and its components increase antiviral immune responses against RNA viruses Frontiers in Pharmacology 2017 8 p. 511 10.3389/fphar.2017.00511 2-s2.0-85026830108 

  28. 28 Rajasekaran D. Palombo E. A. Chia Yeo T. Identification of traditional medicinal plant extracts with novel anti-influenza activity PLoS One 2013 8 11 p. e79293 10.1371/journal.pone.0079293 2-s2.0-84896737450 24312177 

  29. 29 Zhong J. Cui X. Shi Y. Gao Y. Cao H. Antiviral activity of Jinchai capsule against influenza virus Journal of Traditional Chinese Medicine 2013 33 2 200 204 10.1016/S0254-6272(13)60125-9 23789217 

  30. 30 Grosdidier A. Zoete V. Michielin O. SwissDock, a protein-small molecule docking web service based on EADock DSS Nucleic Acids Research 2011 39 suppl W270 W277 10.1093/nar/gkr366 2-s2.0-79960029361 21624888 

  31. 31 Wallace A. C. Laskowski R. A. Thornton J. M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions Protein Engineering 1995 8 2 127 134 10.1093/protein/8.2.127 2-s2.0-0028922586 7630882 

  32. 32 Choi J. G. Jin Y. H. Kim J. H. In vitro anti-viral activity of Psoraleae semen water extract against influenza A viruses Frontiers in Pharmacology 2016 7 10.3389/fphar.2016.00460 2-s2.0-85003874994 

  33. 33 Park M. H. Kim I. S. Kim S. A. Inhibitory effect of Rhus verniciflua Stokes extract on human aromatase activity; butin is its major bioactive component Bioorganic & Medicinal Chemistry Letters 2014 24 7 1730 1733 10.1016/j.bmcl.2014.02.039 2-s2.0-84897446304 24630560 

  34. 34 Cho N. Choi J. H. Yang H. Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines Food and Chemical Toxicology 2012 50 6 1940 1945 10.1016/j.fct.2012.03.052 2-s2.0-84860132077 22465834 

  35. 35 Huang A. C. Wilde A. Ebmeyer J. Skouroumounis G. K. Taylor D. K. Examination of the phenolic profile and antioxidant activity of the leaves of the Australian native plant Smilax glyciphylla Journal of Natural Products 2013 76 10 1930 1936 10.1021/np4005163 2-s2.0-84886818718 24050300 

  36. 36 Kim J. S. Kwon Y. S. Chun W. J. Rhus verniciflua Stokes flavonoid extracts have anti-oxidant, anti-microbial and α -glucosidase inhibitory effect Food Chemistry 2010 120 2 539 543 10.1016/j.foodchem.2009.10.051 2-s2.0-73249143448 

  37. 37 Kim K. H. Moon E. Choi S. U. Pang C. Kim S. Y. Lee K. R. Identification of cytotoxic and anti-inflammatory constituents from the bark of Toxicodendron vernicifluum (Stokes) F.A. Barkley Journal of Ethnopharmacology 2015 162 231 237 10.1016/j.jep.2014.12.071 2-s2.0-84921628912 25582488 

  38. 38 Jeong S. J. Park J. G. Kim S. Extract of Rhus verniciflua stokes protects the diet-induced hyperlipidemia in mice Archives of Pharmacal Research 2015 38 11 2049 2058 10.1007/s12272-015-0579-6 2-s2.0-84947130291 25784057 

  39. 39 Choi J. G. Kim Y. S. Kim J. H. Chung H. S. Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition Scientific Reports 2019 9 1 p. 12132 10.1038/s41598-019-48430-8 2-s2.0-85070995063 31431635 

  40. 40 Haasbach E. Hartmayer C. Hettler A. Antiviral activity of Ladania067, an extract from wild black currant leaves against influenza A virus in vitro and in vivo Frontiers in Microbiology 2014 5 10.3389/fmicb.2014.00171 2-s2.0-84899699314 

  41. 41 Choi J. G. Lee H. Kim Y. S. Aloe vera and its components inhibit influenza A virus-induced autophagy and replication The American Journal of Chinese Medicine 2019 47 6 1307 1324 10.1142/S0192415X19500678 2-s2.0-85072103775 31505936 

  42. 42 Mukhtar M. Arshad M. Ahmad M. Pomerantz R. J. Wigdahl B. Parveen Z. Antiviral potentials of medicinal plants Virus Research 2008 131 2 111 120 10.1016/j.virusres.2007.09.008 2-s2.0-38849181024 17981353 

  43. 43 Lee J. D. Huh J. E. Jeon G. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models International Immunopharmacology 2009 9 3 268 276 10.1016/j.intimp.2008.11.005 2-s2.0-60549095283 19111632 

  44. 44 Ives J. A. L. Carr J. A. Mendel D. B. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo Antiviral Research 2002 55 2 307 317 10.1016/S0166-3542(02)00053-0 2-s2.0-0036294323 12103431 

  45. 45 Kiso M. Mitamura K. Sakai-Tagawa Y. Resistant influenza A viruses in children treated with oseltamivir: descriptive study Lancet 2004 364 9436 759 765 10.1016/S0140-6736(04)16934-1 2-s2.0-4444369826 15337401 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로